VVOS

Vivos Therapeutics, Inc. NASDAQ Listed Dec 11, 2020

Healthcare ·Medical - Devices ·US · vivos.com

$0.65

Mkt Cap $3.8M

52w Low $0.65 0.0% of range 52w High $7.95

50d MA $1.17 200d MA $2.47

P/E (TTM) -0.4x

EV/EBITDA -1.7x

P/B —

Debt/Equity -9.1x

ROE 1420.8%

P/FCF -1.2x

RSI (14) —

ATR (14) —

Beta 6.90

50d MA $1.17

200d MA $2.47

Avg Volume 211.0K

Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers the Vivos System, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. Vivos Therapeutics also offers VivoScore Program, a screening and home sleep test in adults and children. The company markets and sells its Vivos System to licensed professionals, primarily general dentists in the United States and Canada. Vivos Therapeutics, Inc. was founded in 2016 and is based in Highlands Ranch, Colorado.

SIC Code

3841

CIK (SEC)

1716166

Phone

866 908 4867

9137 Ridgeline Boulevard · Highlands Ranch, CO 80129 · US

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Apr 15, 2026	AMC	-0.49	-0.58	-17.2%	1.47	-15.6%	-25.9%	-10.6%	+3.7%	+2.0%	+0.0%	—
Nov 19, 2025	AMC	-0.53	-0.49	+7.5%	2.36	-4.2%	-10.2%	+3.8%	-2.3%	+2.3%	+1.8%	—
Aug 19, 2025	AMC	-0.27	-0.55	-103.7%	4.27	-4.0%	-3.3%	+11.4%	-8.7%	+10.2%	+1.3%	—
May 15, 2025	AMC	-0.44	-0.45	-2.3%	3.06	-5.2%	-17.0%	-9.1%	-6.9%	-3.3%	+0.5%	—
Mar 31, 2025	AMC	-0.43	-0.28	+34.9%	2.85	-1.1%	-7.7%	-2.3%	+0.0%	-0.8%	-1.2%	—
Nov 14, 2024	AMC	-0.70	-0.40	+42.9%	3.12	+1.0%	-9.0%	-4.6%	+4.4%	+2.1%	+2.1%	—
Aug 14, 2024	AMC	-1.05	-0.60	+42.9%	2.37	+4.2%	-5.1%	+3.6%	+11.6%	+17.3%	-6.9%	—
May 14, 2024	AMC	-1.17	-1.63	-39.3%	2.49	-14.5%	-12.4%	+3.7%	+1.3%	-2.2%	-1.8%	—
Mar 28, 2024	AMC	-1.90	-3.05	-60.5%	4.83	-22.4%	-30.2%	+0.6%	-11.2%	+4.3%	-4.1%	—
Nov 14, 2023	AMC	-3.12	-1.75	+43.9%	3.73	+5.9%	+3.2%	+0.8%	+4.1%	+5.9%	+8.6%	—
Aug 16, 2023	AMC	-3.75	-3.75	+0.0%	8.57	-5.8%	-6.9%	-1.9%	-11.5%	-4.3%	-1.5%	—
Jun 8, 2023	AMC	-4.25	-5.00	-17.6%	11.75	+0.0%	-10.2%	+4.3%	+14.5%	-5.6%	+15.8%	—

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Apr 22	Ascendiant Capital	Maintains	Buy → Buy	—	$1.03	$1.05	+1.9%	+0.0%	-13.0%	-6.0%	+2.5%	-1.6%
Apr 17	HC Wainwright & Co.	Maintains	Buy → Buy	—	$1.09	$1.10	+0.9%	-10.6%	+3.7%	+2.0%	+0.0%	-13.0%
Dec 3	Ascendiant Capital	Maintains	Buy → Buy	—	$2.05	$2.04	-0.5%	+1.0%	+3.9%	-3.7%	+4.3%	+0.0%
Sep 9	Ascendiant Capital	Maintains	Buy → Buy	—	$3.83	$3.83	+0.0%	+1.0%	-1.6%	-4.5%	-4.7%	-2.6%
Apr 15	Ascendiant Capital	Maintains	Buy → Buy	—	$2.25	$2.32	+3.1%	-2.7%	-5.0%	+1.0%	+4.8%	+4.5%
Nov 20	Ascendiant Capital	Maintains	Buy → Buy	—	$2.83	$2.86	+1.1%	+2.1%	+2.1%	+8.5%	+5.6%	+4.1%
Nov 19	Alliance Global Partners	Maintains	Buy → Buy	—	$2.71	$2.63	-3.0%	+4.4%	+2.1%	+2.1%	+8.5%	+5.6%
Aug 20	Ascendiant Capital	Maintains	Buy → Buy	—	$2.60	$2.60	+0.0%	+17.3%	-6.9%	-4.9%	+0.4%	+7.4%
Jan 17	Ascendiant Capital	Maintains	Buy → Buy	—	$43.75	$45.00	+2.9%	-6.9%	-6.1%	-2.0%	-9.3%	-2.9%
Aug 12	Roth Capital	Maintains	Buy → Buy	—	$70.50	$70.50	+0.0%	-2.8%	+19.3%	-11.9%	+16.8%	+1.3%
May 17	Roth Capital	Maintains	Buy → Buy	—	$149.25	$148.75	-0.3%	+1.5%	-4.0%	-3.3%	+0.9%	-0.2%
Jan 11	Craig-Hallum	Maintains	Buy → Buy	—	$155.75	$159.00	+2.1%	+16.4%	+12.1%	+0.2%	-2.0%	-5.8%
Jan 5	Roth Capital	Maintains	Buy → Buy	—	$150.25	$152.50	+1.5%	+2.7%	+1.9%	+1.6%	-2.5%	+16.4%

Data updated apr 27, 2026 8:31am · Source: massive.com